Menu Menu

GALT    Galectin Therapeutics Inc    1133416    
Income Statement
Net Income ef20034540_10q -11,220,000

Balance Sheet
Current Assets 28,666,000
Assets 28,972,000
Current Liabilities 25,258,000
Liabilities 123,176,000
Equity -94,204,000
Shares Out 62,278,000

Cash Flow Statement
Operating Cash Flow -28,976,000

Market Analysis
Market Cap 171,887,583
Price 1.58
BVPS 0.15
PB 10.69
EPS -0.78
PS 0.52
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
2.24
Apr May Jun
5/15 -0.19
Jul Aug Sep
8/13 -0.20
Oct Nov Dec
11/14 -0.18

Find a discrepancy? The most accurate way to find company fundamental data is to view GALT documents filed with the SEC.


GALT Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker:



View A List of Tickers





We can also help with your taxes.

Formal Tax

www.formal.tax





(402) 804-8293


Formal Financial App
Google Play - Apple Store

created using: Admin Canvas